Sarepta Therapeutics, Inc. SRPT Net gains (losses) on investments
Net gains (losses) on investments at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s net gains (losses) on investments?
- Sarepta Therapeutics, Inc. (SRPT) reported net gains (losses) on investments of -$1.71M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s net gains (losses) on investments changed year-over-year?
- Sarepta Therapeutics, Inc.'s net gains (losses) on investments increased by 98.1% year-over-year, from -$90.73M to -$1.71M.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.